Evidence map›Paper›PMID 41735356›Full record

SynthesisScientific reports2026

The ubiquitin-proteasome system is an important driver of EBV-associated nasopharyngeal carcinoma progression: a meta-analysis of transcriptomic data.

Hana Ratnawati, Ardo Sanjaya, Aldrich Christiandy, Lawrence S Young, Sascha Ott

Abstract readMeta-Analysis
In one paragraph

Synthesis in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hana Ratnawati *Department of Histology, Faculty of Medicine, Maranatha Christian University, Bandung, 40164, Indonesia.
Ardo Sanjaya *Department of Anatomy, Faculty of Medicine, Maranatha Christian University, Bandung, 40164, Indonesia. ardo.sanjaya@med.maranatha.edu.
Aldrich ChristiandyUndergraduate Program in Medicine, Faculty of Medicine, Maranatha Christian University, Bandung, 40164, Indonesia.
Lawrence S YoungBiomedical Sciences Directorate, Warwick Medical School, University of Warwick, Coventry, CV4 7AL, UK.
Sascha OttBioinformatics & Digital Health Services, Research Technology Platforms, University of Warwick, Coventry, CV4 7AL, UK.

Funding

Maranatha Christian University 023/SK/ADD/UKM/V/2024
6 · The paper itself

Abstract

Epstein-Barr virus (EBV)-associated nasopharyngeal carcinoma (NPC) is characterized by extensive immune infiltration, yet immune evasion remains a hallmark. In this study, we aimed to leverage publicly available datasets to identify EBV-host gene interactions and re-map their expression at single-cell resolution. We conducted a meta-analysis to identify differentially expressed genes, mapped these genes to EBV-host interaction data, constructed a network, and performed pathway enrichment. Single-cell RNA sequencing datasets were used to map these genes at cellular resolution. We analysed differences in cell cycle, immune signaling, cell-cell interactions, and assessed prognostic associations of UPS signature using the GEPIA2 platform. We identified 85 EBV-interacting DEGs regulated by lytic-phase proteins. Clustering highlighted genes related to the ubiquitin-proteasome system (UPS). Single-cell analyses confirmed elevated UPS-related gene expression in NPC. UPS-High cells exhibited lower proliferative activity, enriched stemness signaling, and reduced antigen presentation and immune activation, whereas UPS-Low cells showed marked upregulation of growth-promoting pathways. High UPS expression was associated with poorer outcomes in pan-cancer, head and neck squamous cell carcinoma, and marginally significant in the small NPC datasets. The proportion of UPS-High cells varied widely across patients. UPS activity, influenced by EBV lytic proteins, is linked to immune evasion, stemness, proliferation, and adverse prognosis. These findings support UPS as a potential biomarker and therapeutic target in NPC, warranting validation and functional studies.

Indexed as

Epstein-Barr Virus InfectionsHerpesvirus 4, HumanNasopharyngeal CarcinomaNasopharyngeal NeoplasmsProteasome Endopeptidase ComplexTranscriptomeUbiquitinDisease ProgressionGene Expression ProfilingGene Expression Regulation, NeoplasticHost-Pathogen InteractionsHumansProteasome Endopeptidase ComplexUbiquitinEpstein-Barr virus infectionsImmune evasionNasopharyngeal carcinomaTranscriptomeTumor microenvironmentUbiquitin–proteasome system

Identifiers

PMID41735356
PMCPMC12987939

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.